There’s a lot you can do for your child with 99 dollars.
I took that money and got my daughter’s genes tested, ordering up an analysis of the composition of her very small self and its odds of living a long and healthy life. And in so doing, I in some small way tied her fate to the success of the company doing the analysis, a genetic-testing startup called 23andMe in Mountain View, California.
As 23andMe scales, its business model will shift. Genetic data on a massive scale is likely to be an extremely valuable commodity to pharmaceutical companies, hospitals, and even governments. This is where the real growth potential is.
But first they need spit.
Read the full, original story here: Inside 23andme founder Anne Wojcicki’s $99 DNA revolution
